Journals deny corrections to Chiara Francavilla
Manchester scientist Chiara Francavilla discovered duplicated images in her older papers and submitted correction requests to Molecular Cell and JCB, only to be ignored.
By Leonid Schneider, on research integrity, biomedical ethics and academic publishing
Manchester scientist Chiara Francavilla discovered duplicated images in her older papers and submitted correction requests to Molecular Cell and JCB, only to be ignored.
The story of two data fabricators and Elsevier regulars, Sudheer Khan and Ali Fakhri. Smut Clyde brings them together in this new guest post about nanotechnology
Catherine Jessus resigned, Olivier Voinnet solves the crime he was suspected of, and their mutual investigator Francis-Andre Wollman might want to investigate his own papers
Carlos Lopez-Otin was forced to retract EIGHT papers in the Journal of Biological Chemistry, right after he retracted a very important paper in Nature Cell Biology. Spanish elites cry foul, a letter signed by 50 Spanish researchers was sent to JBC to prevent retractions. The ringleader is Juan Valcarcel of CRG in Barcelona, and I release 3 incompetent investigative reports Valcarcel commissioned in 2015 to whitewash his CRG colleague Maria Pia Cosma.
A scientifically subterranean topic at Frontiers leads to a discovery of cheater talents in Poland: a duo of EU-funded nanofabricators from Pakistan. Does any of their papers contain any actual research data, or is it all just made up?
Manipulated data in 17 papers from one cancer research lab in China gets flagged on PubPeer. It ends with the university hospital in Wuhan issuing a secret statement accusing the US pharma giant a Merck of a conspiracy to slander a Chinese Academy member, Dr Ding Ma.
The team around the paediatric oncologist Nabil Ahmed at Baylor College of Medicine in Houston, Texas, discovered a way to engineer T-leukocytes to bypass the blood-brain barrier at attack otherwise untreatable brain cancers. Their amazing technology to get this published in Nature was brazenly insolent data fakery.
Professor Ruben Plentz chose to focus his career on clinical medicine in Bremen, despite his tremendous academic achievements in cancer research. Was it because malicious critics harassed him with frivolous investigations and corrections, envious at all those peer-reviewed cancer cures the great doctor invented?
On 27 December 2018, I received an email from the Italian Office for Protection of Personal Data. A certain Professor Giorgio Zauli has reported me for publishing an official letter his University of Ferrara sent to me on his behalf.
The 2015 Nature Cell Biology paper by the Spanish cancer researcher Carlos Lopez-Otin and his US partner George Q Daley, stem cell titan and dean of Harvard Medical School, is being retracted. First author and Lopez-Otin’s student Clara Soria-Valles caused Daley even more trouble: her next groundbreaking paper was meant to be already published, but it is not even submitted and might never be.









